The effect of the duration of GnRH-agonist down regulation before ovarian stimulation on the biological and clinical outcome after intracytoplasmic sperm injection
- PMID: 9846679
- DOI: 10.1016/s0301-2115(98)00125-0
The effect of the duration of GnRH-agonist down regulation before ovarian stimulation on the biological and clinical outcome after intracytoplasmic sperm injection
Abstract
The object of this study was to compare the biological outcome (oocyte maturity, fertilization, cleavage) and the clinical outcome after a 'long' (15-24 days) and a 'long-long' (25-40 days) protocol of GnRH-agonist administration for intracytoplasmic sperm injection. Group A consisted of 51 patients with a 15-24-day down regulation period and Group B consisted of 35 patients with a 25-40-day down regulation period, all of which entered ICSI due to severe male factor infertility. Duration and amount of gonadotropin stimulation, serum E2 on the day of hCG administration, number of oocytes retrieved, oocyte maturity, fertilization rate, cleavage rate and pregnancy outcome were comparable for the two groups of patients. Therefore, a flexible period of pituitary desensitization can be employed, allowing us to simplify planning for patients and for the medical staff without affecting the outcome of the trial.
Similar articles
-
Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.Fertil Steril. 2016 Aug;106(2):334-341.e1. doi: 10.1016/j.fertnstert.2016.04.006. Epub 2016 Apr 22. Fertil Steril. 2016. PMID: 27114329
-
Type of stimulation protocol affects oocyte maturity, fertilization rate, and cleavage rate after intracytoplasmic sperm injection.Fertil Steril. 1995 Sep;64(3):557-63. doi: 10.1016/s0015-0282(16)57792-9. Fertil Steril. 1995. PMID: 7641910 Clinical Trial.
-
Prospective randomized study of an ultrashort gonadotrophin-releasing hormone agonist versus a modified suppression protocol for ovarian stimulation in intracytoplasmic sperm injection cycles.Hum Reprod. 1997 Jul;12(7):1403-8. Hum Reprod. 1997. PMID: 9262266 Clinical Trial.
-
GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.Hum Reprod. 2005 May;20(5):1213-20. doi: 10.1093/humrep/deh765. Epub 2005 Mar 10. Hum Reprod. 2005. PMID: 15760966 Clinical Trial.
-
Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.Fertil Steril. 2016 Nov;106(6):1356-1362. doi: 10.1016/j.fertnstert.2016.07.1068. Epub 2016 Aug 1. Fertil Steril. 2016. PMID: 27490046
Cited by
-
Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation.Reprod Biol Endocrinol. 2009 Oct 13;7:110. doi: 10.1186/1477-7827-7-110. Reprod Biol Endocrinol. 2009. PMID: 19825188 Free PMC article. Clinical Trial.
-
Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist.Front Endocrinol (Lausanne). 2022 Oct 7;13:1037220. doi: 10.3389/fendo.2022.1037220. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36277710 Free PMC article.
-
Effects of Different Exposure Days to Gonadotropin-Releasing Hormone Agonist (GnRH-a) on Live Birth Rates in the Depot GnRH-a Protocol: A Retrospective Analysis of 7007 Cycles.Med Sci Monit. 2021 Apr 5;27:e929854. doi: 10.12659/MSM.929854. Med Sci Monit. 2021. PMID: 33814548 Free PMC article.
-
Different ovarian stimulation protocols for women with diminished ovarian reserve.J Assist Reprod Genet. 2007 Dec;24(12):597-611. doi: 10.1007/s10815-007-9181-2. Epub 2007 Nov 22. J Assist Reprod Genet. 2007. PMID: 18034299 Free PMC article. Review.
-
Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.Cochrane Database Syst Rev. 2025 Jan 9;1(1):CD006919. doi: 10.1002/14651858.CD006919.pub5. Cochrane Database Syst Rev. 2025. PMID: 39783453
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical